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Abstract 
Influence diagrams are ideal knowledge 
representations for Bayesian statistical models. 
However, these diagrams are difficult for end 
users to interpret and to manipulate. We present 
a user-based architecture that enables end users to 
create and to manipulate the knowledge 
representation. We use the problem of 
physicians' interpretation of two-arm parallel 
randomized clinical trials (T APRCT) to illustrate 
the architecture and its use. There are three 
primary data structures. Elements of statistical 
models are encoded as subgraphs of a restricted 
class of influence diagram. The interpretations of 
those elements are mapped into users' language 
in a domain-specific, user-based semantic 
interface, called a patient-flow diagram, in the 
T APRCT problem. Pennitted transformations of 
the statistical model that maintain the semantic 
relationships of the model are encoded in a 
metadata-state diagram, called the cohort-state 
diagram, in the T APRCT problem. The 
algorithm that runs the system uses modular 
actions called construction steps. This 
framework has been implemented in a system 
called THOMAS, that allows physicians to 
interpret the data reported from a T APR CT. 
Keywords: statistics, Bayesian, expert systems, 
artificial intelligence, influence diagrams, 
probabilistic reasoning, knowledge acquisition, 
clinical trials. 
1 INTRODUCTION 
Dynamic construction of influence diagrams is a powerful 
strategy for enabling a computer-based system to match a 
human's knowledge. During statistical analysis, the 
analyst creates a model of the domain and of the data, so 
such dynamic construction is crucial when creating 
intelligent systems for statistical analysis. Influence 
diagrams are ideal knowledge representations for statistical 
models, especially for Bayesian statistical models (Smith 
1989). However, the use of Bayesian statistics needs the 
end user to direct much of the analysis, because of the 
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importance of the user's prior knowledge of the domain. 
Unfortunately, by the very nature of the complexity and 
technicality of Bayesian statistical models, the typical end 
structures of these models or the implications of any 
choices for important issues like methodological concerns 
or prior knowledge. 
Our thesis is that a user-based semantic interface to 
influence-diagram construction will allow such users to 
perform a meaningful Bayesian-statistical analysis. We 
shall demonstrate a program architecture we call user based 
(UB) that can serve as the basis for building a wide variety 
of such systems. We shall target a particular user 
community throughout this paper: physician readers of 
reports of clinical trials, specifically, two-arm parallel ran-
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Figure 1: The System architecture. (a) General. 
(b) Particular to the case of the TAPRCT problem. 
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Table 1: Elements of the influence-diagram representation of statistical models. 
Object Class Influence-Diagram Element Statistical-Model Interpretation 
Level Population General knowledge 
Sample Study-specific knowledge 
Effective Measured knowledge 
Patient Patient-specific knowledge 
N<XIe Outcome e.g., Lifespan 
Arc 
Parameter 
Outcome 
Methodological 
Interlevel 
Population---7 Study 
Study ---7 Effective 
Isotypal 
Population ---7 population 
Sample ---7 sample 
Heterotypal 
Methodological ---7 outcome 
domized clinical trials (T APRCT). These are studies 
where patients are randomly assigned to one of two 
therapies; often, one of them is a placebo control 
treatment. The principles of using the architecture, 
however, are genetic. 
Fig. 1 depicts the architecture. In Section 2, we shall 
discuss statistical models, in Section 3, the semantic 
interface, in Section 4, metadata and the metadata-SL:'lte 
diagram, and in Section 5, the construction steps. �n 
Section 6, we shall discuss an implementation of tl11s 
architecture, in Section,? we discuss previous work, and 
conclude in Section 8. 
2 STATISTICAL MODEL 
A statistical model comprises elements, interpretations, 
and transformations. Elements of a statistical model 
include: probability models, parameters, observations, 
and assumptions that allow the analyst to relate tl1e 
observations to the parameters. Interpretations map 
elements of the statistical model into inferential concems 
in the world. Transformations are the permitted 
operations that change the statistical model, while 
maintaining tl1e interpretations of the model. 
In the UB m·chitecture, we use influence diagrams 
(Howard and Matheson 1981; Oliver and Smith 1990) to 
represent the elements of statistical models (Smith 1989). 
As generally described, there m-e two classes of o�jects in 
these acyclic, directed graphs. Nodes are the objects of 
interest: pm-ameters, observations, decision options and 
decision objectives. Note that parameters and 
observations m-e continuous quantities, unlike the discrete 
variables for which influence diagrams have been 
traditionally used in AI systems. Arcs are objects 
e.g., Mortality rate 
e.g., Withdrawal rate 
External validity e.g., Selection bias 
Measurement reliability e.g., Specificity 
Domain knowledge 
e.g., Placebo population mortality rate = baseline 
population mortality rate 
Internal validity e.g., Withdrawal model 
Specific relationships e.g., Mixture models 
representing dependencies; tl1e absence of an m-c between 
two nodes denotes the independence of tl1e vatiables those 
nodes represent. 
To aid t11e communication with users, we add level as a 
third object. Levels m-e elements that contain nodes and 
give tl10se nodes interpretive semantics (e.g., population 
mortality rate as opposed to sample mortality rate). 
Levels limit the transformative interactions among 
pm·mneters. The specific levels we use for the T APRCT 
problem m·e as follows (see Table 1): effective level 
allows for modeling concerns regm-ding measurement 
reliability; t11e sample level allows for modeling concems 
regm·ding intemal validity; the population level allows for 
modeling concerns regarding extemal validity; and the 
patient level allows us to represent differences between the 
patient and the population. Fig. 2 depicts the initial 
influence-diagram of the statistical model for the 
T APRCT problem. 
In the UB m-chitecture, we m-e concerned primru-ily with 
transformations tlwt signify methodological concems 
noted by the reader of t11e study report. We use 
construction steps tlmt transform tl1e statistical model to 
comply with the interpretative meaning of the 
methodological concern (see Section 5). The steps m-e 
moduhu· statements of permitted transformations. This 
modulm·ity will allow tl1e user to take as much charge of 
the interaction with the machine as possible. Note that 
modification of a statistical model is, by definition, model 
dliven; t11e nature of the model permits or forbids different 
types of modification. 
50 Lehmann and Shachter 
Population 
Study 
� 
 
Effective 
Patient 
Figure 2: Initial influence-diagram of the statistical model for a TAPRCT. The diagram is divided into four levels 
(Population, Study, Effective, and Patient), with experimental (exp) and control (ctl) outcome parameters((}) in each 
level (plus a baseline outcome parameter in the population level). The parameters in the study, effective, and patient 
levels are functionally dependent on the population-level parameters; the latter are represented as oval chance nodes, 
the fanner, as doubly bordered deterministic nodes. 
Fig. 3 exhibits the representation of a particular bias in 
an T APRCT, showing a part of t11e influence-diagram 
representation of a trial before and after the construction 
step of including the methodological concern of 
withdrawall (for simplicity, only the study level is 
shown). The construction has remodeled the dependence 
of the study parameter: no longer identical to a 
population parameter (t11e initial, default relationship), it 
is now a function of a mixture of other parameters.2 The 
mixture parameter represents t11e witl1drawal rate. In a 
classical-statistical system, its value would be estimated 
from tlle data in tlle study. In a B ayesian system, its 
value would depend on the prior belief of the analyst­
what witlldrawal rate she would expect in t11is type of 
study-as well as on the data observed. The modular 
concept for tllis bias is tlle recognition tlmt withdrawals 
affects tlle study parameter only, and in a particular way. 
1 Withdrawal refers to patients who no longer follow the study protocol, 
but about whom outcome data are known. 
2Left out of Fig. 2 are the dependencies of the other study parameters 
on particular population parameters. For instance, the outcome study 
parameter in patients assigned to experimental treatment but who 
withdrew from therapy is made functionally identical on the standard­
care population parameter. 
3 SEMANTIC INTERFACE: THE 
PATIENT-FLOW DIAGRAM 
Most statistical clients require an interface tllat translates 
elements of a statistical model into a language whose 
semantics tlley understand. For tlle UB architecture, we 
chose as t11e metaphor for tlle semantic interface tlle 
patient-flow diagram. In such a diagram, children nodes 
represent cohort at a particular point in time. 
Modification of a cohort is akin to a traversal from one 
state of knowledge to cohorts of patien� whose numbers 
sum to that of the parent node, but each of whom 
experienced an important different event in tlle study. A 
patient-flow diagram depicts the history of patients in tlle 
course of a study and is often published in a report of a 
clinical trial. Users manipulate t11e statistical model by 
m�mipulating the patient-flow diagram-tlle domain-based 
metaphor. For instance, t11ey might select a cohort and 
communicate (e.g., via a pop-up menu) that some patients 
in tlle cohort witlldrew from tlle assigned tllerapy. Note 
t11at, in contrast to the statistical model, modification of 
the patient-flow diagram is data driven. 
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Figure 3: Influence-diagram representation of adding the potential bias of withdrawals. (a) Before adding the bias. 
Only the study-level experimental outcome parameter (e) shown. The dependency of the parameter on a population­
level parameter is indicated by the incoming arc. (b) After adding the bias. The study-level outcome parameter is 
now dependent on two other outcome parameters, one for each subcohort (the subcohort of patients who did withdraw 
from the study (exp,withd) and the subcohort where they did not), as well as a new, methodological parameter; this a 
parameter is called a mixture parameter. The study-level dependence on the population level is now through the 
su b c o h o r t  o u t c o m e  pa r a m e t e r s  
4 METADATA-STATE DIAGRAM: THE 
COHORT-STATE DIAGRAM 
The metadata-state diagram (MDSD) mediates between the 
user's data-driven manipulation of the patient-flow 
term refers to knowledge about what sorts of information 
are contained in cohorts and in nodes, and what 
modifications are permitted. The MDSD for the 
T APRCT problem is called the cohort-state diagram. (see 
Fig. 4). The state in this diagram refers to the state of 
knowledge regarding a another; implementing that change 
of state results in changing the statistical model, as well 
as the patient-flow diagram. The diagram aspect of the 
MDSD is the set of path traversals permitted. For the 
T APRCT problem, it represents, fm' instance, the 
methodological knowledge (based on the definition of loss 
to followup) that if a statistical model currently reflects 
the fact that a cohort of patients has been lost to 
followup, then the user's .attempt to provide evidence 
about that cohort should be denied; tile traversal fmm state 
A to B in Fig. 4 is forbidden. 
In summary, a cohort in the patient-flow diagnun points 
to a state in the metadata-state diagram. The cohort also 
points to study and effective outcome parameters (such as 
mortality rates) in the influence diagram (statistical 
model). Evidence within a cohort becomes a node in the 
influence diagram, dependent on the effective outcome 
parameter associated with tile cohort. The relationship 
between population outcome parameter and study outcome 
parameter reflects domain knowledge. 
diagram and the program model-driven modification of the 
statistical model. Metadata refers to information about 
data (Chytil 1986). In the UB architecture, this 
5 CONSTRUCTION STEPS 
The top-level controlling algorithm works as follows: 
The user completes an interaction with the patient-flow 
diagram. The patient-flow diagram then translates the 
user's metadata directive into a machine-usable format that 
includes the metadatum and the target cohort. Unless the 
directive signals tetmination of the modeling process, the 
system examines the cohort-state diagram to determine 
whether tile directive is pennitted, by inspecting the arcs 
emanating from the target cohort's state in the diagram. If 
the directive is permitted, the system then executes the 
corresponding construction step, modifying the patient­
flow diagram and the statistical model in the process. If 
new statistical parentless parameters are created by the 
construction step, the user is asked to assess prior beliefs 
about those parameters; the constructed names of the 
parameters are meaningful to the physician user. 
Names for new parameters are created by concatenating 
phrases associated with transitions in the metadata-state 
diagram, modified by knowledge available to the system 
regarding the target cohort. For instance, a new 
withdrawal-cohort study outcome parameter will be called 
study <outcome> <parameter type> for patients who 
withdrew from therapy in <name of parental cohort>, 
where <outcome> might be mortality, <parameter type> 
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might be rate, and <name of parental cohort> is available 
from the patient-flow diagram. 
As an example, consider the pseudocode for the 
withdraw-transition. There are two major methods 
for this object: pfd-action and s m - a c t i o n, 
corresponding to the construction steps performed on the 
patient-flow diagram and on the statistical model, 
respectively. 
(method pfd-action (withdraw-transition, 
source-cohort) 
withdraw-cohort (- create-cohort(yes) 
no-withdraw-cohort (- create-cohort(no) 
connect (source-cohort, withdraw-cohort) 
connect (source-cohort, no-withdraw-
cohort) 
treatment (withdraw-cohort (source-cohort)) 
(- baseline-treatment 
) 
Two new cohorts ru·e created, with differing semantics as 
regards the withdrawal status of patients in those cohorts. 
The cohorts are then incorporated into the patient-now 
diagram. Finally, an element of domain knowledge is 
included, that withdrawn patients effectively receive 
baseline care. 
(method sm-action(withdraw-transition, source­
cohort) 
alpha (- create-mixing-parameter(sout·ce­
cohort) 
withdraw-outcome-parameter (- outcome­
parameter(withdraw-cohort(source­
cohort)) 
no-withdraw-outcome-pat·ameter (­
outcome-parameter(no-withdraw-cohort 
(source-cohort)) 
make-mixture(source-cohort-outcome­
parameter,  
alpha, withdraw-outcome-parameter, 
no-withdraw-outcome-parameter) 
make-identical( withdraw-outcome-parameter, 
population-baseline-outcome-parameter) 
make-identical(no-withdraw-outcome 
parameter ,population-outcome­
parameter(treatment(source-cohort)))) 
Here, the mtxmg model of Fig. 3 is created. The 
parameters here are all at the srunple level; the functions 
that find the study-level parameters have been eliminated 
for the sake of simplicity. The action, make-mixture, 
is here performing the main work, converting a parameter 
(source-cohort-outcome-parameter) formerly identical to a 
population-level parameter into one that is a deterministic 
function of other parameters. Domain knowledge in 
encoded in the instruction to make, the newly created 
study-level outcome parameters identically deterministic 
on outcome parameters in the population level,. 
6 IMPLEMENTATION 
The architecture presented here has been implemented in a 
system called THOMAS (Lehmann 1991), that focuses 
on problems of intemal validity in T APRCT studies. The 
int1uence diagrams are restricted to having one layer of 
marginally independent chance nodes whose pdfs are beta 
distributions. All other nodes are deterministic or 
evidential. Evidence nodes have only one parent. The 
construction steps are modules whose statistical 
components are based on the methodological models of 
Eddy, et al. (Eddy, Hasselblad et al. 1991). 
The primary outputs are posterior distributions for the 
parameters of the model, and expected utility (life 
expectancy). The algorithm for calculating posterior 
probabilities uses posterior-mode detetmination, based on 
modified Newton-Raphson steepest descent (Shachter 
1990), using the approach of Berndt and colleagues 
(Berndt, Hall et al. 1974). This algorithm requires matrix 
inversion, an 0(m3) process, where m is the number of 
parameters with no parents. In our use of this algorithm, 
parameters that are functionally identical to other 
parameters are eliminated from the model in O(n) time 
prior to the posterior-mode determination, where n is the 
number of statistical parameters. Thus, the overhead of 
maintaining the influence-diagrrun levels takes little away 
from the performance of the algoritlun. 
Calculation of expected utility is through unidimensional 
integration. 
THOMAS is implemented on a Macintosh II computer. 
The patient-flow diagram was written in HyperTalk and 
the remainder of the system was written in Macintosh 
Common Lisp, using the Cmnmon Lisp Object System 
to house the various objects in the UB architecture. 
Communication between the t wo systems used 
TalkToMe, a precursor to AppleEvents. 
A number of different MDSDs and different patient-flow 
diagrams were tested in this architecture. In each 
experiment, and as desired, modifications of a major 
structure did not require changes in the other structure. 
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Figure 4: Metadata-state diagram. States represent cohorts, and arcs represent permitted transitions in states of 
knowledge about cohorts. 
A small number of clinicians used THOMAS as intended. 
The needed tasks were conceptually familiar. Some users 
disliked the navigational interface, but found the patient­
flow diagram to be self-evident (as we expected). 
7 OTHER WORK 
This work reflects on research in the AI-and-stati�tics 
community, in the biostatistical community, and in the 
AI-and-uncertainty community. Statisticians applying AI 
In the biostatistical community, Hasselblad and Eddy have 
developed the F AST*PRO program (associated wit11 
(Eddy, Hasselblad et al. 1991)) to allow medical 
researchers construct influence diagrams that represent 
statistical models. Differences with our work include their 
focus on the data-driven direction of influence-diagram 
construction and their lack of a semantic inte1face. 
Finally, various researchers of AI and uncertainty have 
built systems that automatically build influence diagrams. 
Goldman and Chamiak (Goldman and Chamiak 1990) 
have developed a language for constructing influence 
diagrams, specifically for the domain of natural-language 
processing. Their system uses a hienu·chical and typed 
influence diagram, as we do; their construction algorithm 
is more model-driven than is ours. Similarly, Breese 
(Breese 1987) has built a system that constructs influence 
diagrams out of modular components. However, he 
techniques to statistical problems have, by and large, 
focused on helping the statistical analyst, rather than the 
end user (Nelde and Wolstenhome 1986; Lubinsky 1987; 
Oldford and Peters 1988). 
requires the user to have a greater knowledge of influence 
diagrmns t11m1 we do. 
8 CONCLUSION 
We have presented an architecture for creating tools that 
allow end users to interpret t11e results of scientific studies 
whose data requires statistical analysis for interpretation. 
This architecture implements the general decision-analytic 
approach to scientific inference presented by Lehmann 
(Lehmann 1990). We believe that this architecture could 
be extended for other data-analysis problems. For 
instance, for crossover studies, where patients are first 
given one, then anot11er treatment, the MDSD and the 
patient-flow diagram would both have to be modified. 
Furthermore, t11e m·chitecture could be extended to account 
for other methodological concerns. For instance, 
randomization is a key consideration whose goal is to 
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assure similarity of treatment groups. This concern can 
be represented at the sample level in tenus of relative 
occurrences of covariate states for study subjects in every 
treatment ann, and in tenns of their relative contributions. 
Even more generally, we might imagine that this 
architecture would be suitable for other AI domains where 
the primary user (or even knowledge engineer) may wish 
to be protected from details of Bayesian modeling. Thus, 
in a vision system, the cognate of the patient-flow 
diagram might be the hierarchy of visual perception that 
Levitt and colleagues (Binford, Levitt et al. 1987) have 
put to such good use, while the MDSD might represent 
pennitted, meaningful sequences of visual processing. 
Each limb of transition in that process would have 
implications for the underlying influence diagram as well 
as for an interface that a user would face. 
In each case, there are several tasks for the knowledge 
engineer. First, he must decide the propriety of the 
architecture. Second, from observation of users, he must 
decide on the appropriate semantic metaphor and on tl1e 
central object of manipulation. Third, from discussions 
with domain experts, he must encode the rules for 
transitions. Finally, he must figure out what influence 
diagram structures and transformations embody the 
experts' intentions. This overall construction task is far 
from being automated. 
In summary, statisticians confront the same problem that 
Al-system designers do: How should valid inferences be 
made from real-world data? The user-bao;;ed architecture can 
be of service to both these communities. 
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